Status:

UNKNOWN

From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis

Lead Sponsor:

Nantes University Hospital

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

MS is a heterogeneous disease either in its response to treatment or clinical manifestation. Indeed, the natural history of MS is varying from a benign condition to a devastating and rapidly incapacit...

Eligibility Criteria

Inclusion

  • Inclusion Criteria :
  • Common criteria for retrospective MS patients:
  • Patients aged 18 years or older
  • Clinical isolated syndrome (CIS) with or without dissemination in space
  • Patients affiliated to an appropriate health insurance
  • Criteria for Aggressive MS group
  • • Start of a 2nd line therapy within the two years following the CIS
  • Criteria for Non aggressive MS group
  • No conversion according to McDonald criteria from clinical isolated syndrome to multiple sclerosis within 2 years or
  • Conversion based to McDonald criteria treated or not with first line disease modifying therapy within 2 years.
  • Have a minimum of least 2 years of follow-up.
  • Healthy volunteers
  • Aged 18 years or older
  • No history of clinically isolated syndrome or MS
  • Pairing criteria :
  • Age +/- 5 years
  • Sex
  • Prospective MS Patients
  • Patients aged 18 years or older
  • Clinical isolated syndrome (CIS) with or without dissemination in space
  • Patients affiliated to an appropriate health insurance
  • Exclusion Criteria :
  • Ongoing participation to a another study
  • Refusal to genetic analyses
  • Immunosuppressive drug at the time of blood collection
  • Adults under a legal protection regime (guardianship, trusteeship, judicial safeguard)
  • Pregnancy

Exclusion

    Key Trial Info

    Start Date :

    January 24 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 24 2025

    Estimated Enrollment :

    130 Patients enrolled

    Trial Details

    Trial ID

    NCT04873492

    Start Date

    January 24 2022

    End Date

    July 24 2025

    Last Update

    January 30 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Nantes University Hospital

    Nantes, Loire-Atlantique, France, 44093